4/A//SEC Filing
Hernday Natasha 4/A
Accession 0001415889-24-020056
CIK 0001817713other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 8:00 PM ET
Size
7.4 KB
Accession
0001415889-24-020056
Insider Transaction Report
Form 4/AAmended
Hernday Natasha
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-07-19+4,111→ 4,111 totalExercise: $44.68Exp: 2034-07-18→ Common Stock (4,111 underlying) - Award
Common Stock
2024-07-19+1,231→ 6,231 total
Footnotes (2)
- [F1]Represents the grant of RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on July 19, 2025, subject to the Reporting Person's continuous service on such date.
- [F2]The shares subject to the option will vest in twelve equal monthly installments over one year, subject to the Reporting Person's continuous service on each such date.
Documents
Issuer
Janux Therapeutics, Inc.
CIK 0001817713
Entity typeother
Related Parties
1- filerCIK 0001780547
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 8:00 PM ET
- Size
- 7.4 KB